APOGEPHA Arzneimittel
Manufacturing · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Kyffhäuserstraße 27, Dresden, Saxony, 01...Phone Number
+49 35133633Website
www.apogepha.deRevenue
$19 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About APOGEPHA Arzneimittel
Apogepha is an independent German pharmaceutical company that specializes in the field of Urology. The company has its own production facilities and developed propiverine, one of the leading medicines for the treatment of overactive bladder in adults and children. Various dosages and formulations of propiverine are available worldwide under trademarks such as Mictonorm® and Detrunorm®. The patent for the once-daily formulation of propiverine has been approved in most countries. Currently, Apogepha has marketing and distribution partners in more than twenty countries, with a focus on Europe and Asia.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is APOGEPHA Arzneimittel your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if APOGEPHA Arzneimittel had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at APOGEPHA Arzneimittel
Product Launch: Get notified when APOGEPHA Arzneimittel launches new products
APOGEPHA Arzneimittel, which may be a good buyer, showed buying intent in Masked Content Topic
Check if APOGEPHA Arzneimittel has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once APOGEPHA Arzneimittel has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on APOGEPHA Arzneimittel recently announced quarterly report
Check out if APOGEPHA Arzneimittel is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined APOGEPHA Arzneimittel as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
APOGEPHA Arzneimittel is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
APOGEPHA Arzneimittel is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about APOGEPHA Arzneimittel.
APOGEPHA Arzneimittel Tech Stack
APOGEPHA Arzneimittel News & Media
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a non-binding letter of intent (the “LOI”) with APOGEPHA Arzneimittel GmbH (“APOGEPHA”) in which both parties will analyze the potential for APOGEPHA to distribute NanoVibronix’s premiere UroShield product in Germany and other European m
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding APOGEPHA Arzneimittel
Sign Up For FreeTo access detailed company insights
Apogepha is an independent German pharmaceutical company that specializes in the field of Urology. The company has its own production facilities and developed propiverine, one of the leading medicines for the treatment of overactive bladder in adults and children. Various dosages and formulations of propiverine are available worldwide under tradema... Read More
